Analysts See Upside in iShares Core U.S. Growth ETF

Analysts predict a 23.67% upside for the iShares Core S&P U.S. Growth ETF (IUSG), trading at $132.34, with expectations of reaching $163.66 based on underlying holdings. Notably, Kirby Corp. (KEX), Belden Inc. (BDC), and Globus Medical Inc. (GMED) show significant potential for price increases.

Date: 10-03-2025

AI Rating: 7

Upside Potential for IUSG: The report indicates that iShares Core S&P U.S. Growth ETF (IUSG) is currently priced at $132.34, while analysts have a 12-month price target of $163.66. This suggests a projected upside of 23.67%, indicative of potential growth in investor sentiment towards the ETF.

Individual Holdings Performance: The report also highlights three underlying holdings of IUSG, namely Kirby Corp. (KEX), Belden Inc. (BDC), and Globus Medical Inc. (GMED). Each of these companies has a substantial projected upside according to analysts:

KEX is currently priced at $97.13 with an average target of $135.50, showing a potential upside of 39.50%.
BDC is at $104.47, with a target price of $133.20, reflecting a 27.50% potential increase.
GMED has a recent price of $77.41 and an analyst target of $98.69, indicating a 27.49% upside.

This projected upside growth across these holdings suggests a strong bullish outlook from analysts, which could positively influence stock prices if the anticipated targets are met or even approached. However, analysts caution that such optimism should be met with careful investor research to validate these targets against current industry and company developments.

Stocks: IUSG KEX BDC GMED